Researchers in Japan have identified a surprising candidate for tackling one of Alzheimerโ€™s diseaseโ€™s most persistent biological features: the sticky protein clumps known as amyloid-beta. A new study reports that oral doses of the amino acid arginineโ€”already widely used as a safe medication for other conditionsโ€”can disrupt these toxic aggregatesContinue Reading